FDA
approval
· 2025-02-21
FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
Summary
FDA approved a supplemental application for Suboxone (buprenorphine hydrochloride, naloxone hydrochloride) from Indivior Inc. to modify the existing approval.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE)